Log In
Print
BCIQ
Print
Print this Print this
 

ADXS-HPV (ADXS11-001) (formerly Lovaxin C)

  Manage Alerts
Collapse Summary General Information
Company Advaxis Inc.
DescriptionLive Listeria monocytogenes-based immunotherapy expressing E7 transforming protein (Human papillomavirus-16) (HpV16gp2)
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today